Bajaj HealthCare Limited (BAJAJHCARE.BO)
INR 593.0
(6.08%)
INR 593.0
(6.08%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 507.38 Million | -223.23 Million | 6.86 Million | 435.58 Million | 205.74 Million | 251.68 Million |
| Net Income | -143.26 Million | 582.16 Million | 896.84 Million | 1.18 Billion | 360.6 Million | 241.69 Million |
| Depreciation & Amortization | 276.19 Million | 273.55 Million | 176.36 Million | 161.24 Million | 121.23 Million | 114.1 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 385.05 Million | -1.24 Billion | -1.1 Billion | -640.91 Million | -219.07 Million | -60.39 Million |
| Other non-cash items | 211.62 Million | 169.93 Million | 42.04 Million | -272.93 Million | -57.01 Million | -43.71 Million |
| Investing Cash Flow | -115.64 Million | -934.26 Million | -747.98 Million | -1.08 Billion | -275.6 Million | -130.25 Million |
| Investments in PPE | -302.86 Million | -1.23 Billion | -793.04 Million | -1.13 Billion | -226.89 Million | -150.05 Million |
| Acquisitions | 112.5 Million | 307.74 Million | 51.15 Million | 1.89 Million | 974 Thousand | 83.17 Thousand |
| Investment purchases | - | - | - | 1.66 Million | -50 Million | - |
| Sales/Maturities of investments | 74.71 Million | - | - | 50 Million | 3.09 Million | - |
| Other Investing Activities | 7.54 Million | -3.59 Million | -6.08 Million | -5 Million | -2.77 Million | 19.72 Million |
| Financing Cash Flow | -547.2 Million | 1.31 Billion | 618.46 Million | 754.57 Million | 32.82 Million | -125.67 Million |
| Debt repayment | -517.29 Million | -1.58 Billion | -758.5 Million | -861.68 Million | -97.31 Million | -40.82 Million |
| Dividends payments | -27.59 Million | -41.39 Million | -13.8 Million | -24.14 Million | - | -6.89 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2000.00 | 2.94 Billion | 1.39 Billion | 1.64 Billion | 130.13 Million | -77.94 Million |
| Accounts receivables | 125.96 Million | -474.24 Million | -860.44 Million | 3.51 Million | -220.05 Million | 22.57 Million |
| Accounts payables | - | - | - | - | - | 1.00 |
| Inventory | 204.2 Million | -495.24 Million | -621.51 Million | -578.35 Million | -92.27 Million | 36.11 Million |
| Other working capital | 54.89 Million | -279.4 Million | 373.56 Million | -66.07 Million | 93.25 Million | -119.09 Million |
| Cash at beginning of period | 177.2 Million | 19.75 Million | 142.41 Million | 41.58 Million | 78.61 Million | 82.85 Million |
| Cash at end of period | 29.28 Million | 177.2 Million | 19.75 Million | 142.41 Million | 41.58 Million | 78.61 Million |
| Capital Expenditure | -302.86 Million | -1.23 Billion | -793.04 Million | -1.13 Billion | -226.89 Million | -150.05 Million |
| Effect of forex changes on cash | - | - | -1000.00 | - | - | - |
| Net cash flow / Change in cash | -147.91 Million | 157.45 Million | -122.66 Million | 100.82 Million | -37.03 Million | -4.24 Million |
| Free Cash Flow | 204.52 Million | -1.46 Billion | -786.18 Million | -702.3 Million | -21.14 Million | 101.62 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -299.24 Million | -143.26 Million | -21.96 Million | -34.6 Million | -482.11 Million | 582.16 Million |
| Depreciation & Amortization | - | 276.19 Million | 73.54 Million | 66.6 Million | 63.07 Million | 273.55 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 385.05 Million | - | - | - | -1.24 Billion |
| Other non-cash items | 299.24 Million | 211.62 Million | 21.96 Million | 34.6 Million | 482.11 Million | 169.93 Million |
| Investing Cash Flow | - | -115.64 Million | - | - | - | -934.26 Million |
| Investments in PPE | - | -302.86 Million | - | - | - | -1.23 Billion |
| Acquisitions | - | 112.5 Million | - | - | - | 307.74 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 74.71 Million | - | - | - | - |
| Other Investing Activities | - | 7.54 Million | - | - | - | -3.59 Million |
| Financing Cash Flow | - | -547.2 Million | - | - | - | 1.31 Billion |
| Debt repayment | - | -517.29 Million | - | - | - | -1.58 Billion |
| Dividends payments | - | -27.59 Million | - | - | - | -41.39 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -2000.00 | - | - | - | 2.94 Billion |
| Accounts receivables | - | 125.96 Million | - | - | - | -474.24 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | 204.2 Million | - | - | - | -495.24 Million |
| Other working capital | - | 54.89 Million | - | - | - | -279.4 Million |
| Cash at beginning of period | - | 177.2 Million | 103.38 Million | 52.15 Million | 177.2 Million | 19.75 Million |
| Cash at end of period | - | 29.28 Million | 55.24 Million | 103.38 Million | 70.26 Million | 177.2 Million |
| Capital Expenditure | - | -302.86 Million | - | - | - | -1.23 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -147.91 Million | -48.14 Million | 51.23 Million | -106.93 Million | 157.45 Million |
| Free Cash Flow | - | 204.52 Million | 55.24 Million | 51.23 Million | 70.26 Million | -1.46 Billion |
POLYMED
IFSUF
CSPI
3417
0295
FISB